FDA Issues Draft Guidance on Deeming Drugs, Medical Devices Adulterated for Inspection Delays
- December 16, 2022
Medical devices could be deemed adulterated when a manufacturer delays, denies, or limits a Food and Drug Administration (FDA) inspection under new draft guidance, according to a notice published in the December 16 Federal Register.
ARTICLE TAGS
You must be logged in to access this content.